(Q44981828)

7 December 2017

title

Functional analysis of apoptosis induction in acute myeloid leukaemia-relevance of karyotype and clinical treatment response (English)

1 reference

7 December 2017

0 references

1 reference

3

Claudia Schoch

1 reference

7 December 2017

Jan Braess

1

1 reference

7 December 2017

Peter Schneiderat

2

1 reference

7 December 2017

Michael Fiegl

4

1 reference

7 December 2017

Isolde Lorenz

5

1 reference

7 December 2017

Wolfgang Hiddemann

6

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

British Journal of Haematology

7 December 2017

published in

1 reference

7 December 2017

volume

126

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

338-347

1 reference

Long-term survival after chemotherapy for acute myeloid leukemia: the experience of the Southwest Oncology Group

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Molecular genetics of acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Treatment of relapsed and refractory acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias. Results of a clinical phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Influence of serum protein binding on the uptake and retention of idarubicin by sensitive and multidrug resistant human leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

In vivo analysis of the molecular genetics of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

Role of protein kinase C zeta isoform in Fas resistance of immature myeloid KG1a leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05039.X

10.1111/J.1365-2141.2004.05039.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference